Glycadia

Manufacturing · Pennsylvania, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

1880 John F Kennedy Blvd Ste 200, Philad...

Phone Number

(215) 557-8021

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Glycadia

Glycadia Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapeutics for the prevention and treatment of kidney, eye, cardiovascular, and related diseases stemming from diabetes. The company aims to address the significant healthcare needs of over 100 million individuals in the United States who suffer from diabetes-related complications. Glycadia's product pipeline includes innovative compounds such as GLY-230, GLY-220, and A717 mAb, targeting diabetic nephropathy, macrovascular, and microvascular diseases. With a commitment to discovery, Glycadia is advancing its clinical trials to bring effective solutions to patients at risk.Explore more
Glycadia's Social MediaPopular SearchesGlycadia IncGlycadiaGlycadia PharmaceuticalsSIC Code 28,283NAICS Code 32,325Show more

Glycadia Org Chart

PhoneEmail
SA
United States flag for contact location.

Chief Business Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
GL
United States flag for contact location.

Manager, Production

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Glycadia your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Glycadia

Compare insights from companies similar to Glycadia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Glycadia

<$5M
11-50
Private
-
1988
SA
Sarabjit AshtaChief Business Officer
<$5M
11-50
Private
-
2006
<$5M
11-50
Private
-
2006
CB
Chadia Balero TakataRadiestesia Genética
<$5M
11-50
Private
-
-
WM
William McVicarExecutive Vice President & Scientific Chief & Officer
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
<$5M
2017
JK
James KirwinChief Operating Officer & Senior VP, Clinical Development
<$5M
1-10
Private
-
2014
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Glycadia is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Glycadia is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Glycadia.

Glycadia Tech Stack

Top Manufacturing Companies

Frequently Asked Questions Regarding Glycadia

What is Glycadia's official website?
Glycadia's official website is www.glycadia.com
What is Glycadia's Revenue?
Glycadia's revenue is <$5 Million
What is Glycadia's SIC code?
Glycadia's SIC: 28,283
What is Glycadia's NAICS code?
Glycadia's NAICS: 32,325
How many employees does Glycadia have?
Glycadia has 11-50 employees
What industry does Glycadia belong to?
Glycadia is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Glycadia competition?
Glycadia top competitors include: SFA Therapeutics, Laminar Pharmaceuticals, Novoclinica, Pipeline Drugs
What technology does Glycadia use?
Some of the popular technologies that Glycadia uses are: WordPress.org, Google Font API, DreamHost, Rackspace Email Hosting
How do I contact Glycadia?
Glycadia contact info: Phone number: (215) 557-8021 Website: www.glycadia.com
What does Glycadia do?

Glycadia Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapeutics for the prevention and treatment of kidney, eye, cardiovascular, and related diseases stemming from diabetes. The company aims to address the significant healthcare needs of over 100 million individuals in the United States who suffer from diab... etes-related complications. Glycadia's product pipeline includes innovative compounds such as GLY-230, GLY-220, and A717 mAb, targeting diabetic nephropathy, macrovascular, and microvascular diseases. With a commitment to discovery, Glycadia is advancing its clinical trials to bring effective solutions to patients at risk.Read More

What are Glycadia social media links?
Glycadia Linkedin page
Is Glycadia a public company?
Glycadia is private company therefore does not currently have an official ticker symbol
See more information about Glycadia

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.